Edgar Filing: TERADYNE, INC

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 2, 2011

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No. 001-06462

TERADYNE, INC.

(Exact name of registrant as specified in its charter)


Massachusetts		04-2272148
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)

600 Riverpark Drive, North Reading, Massachusetts		01864
(Address of Principal Executive Offices)		(Zip Code)

978-370-2700

(Registrant’s Telephone Number, Including Area Code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files) Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares outstanding of the registrant’s only class of Common Stock as of November 7, 2011 was 184,056,173 shares.

TERADYNE, INC.

INDEX


		Page No.

PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements (unaudited):

	Condensed Consolidated Balance Sheets as of October 2, 2011 and December 31, 2010		3

	Condensed Consolidated Statements of Operations for the Three and Nine Months Ended October 2, 2011 and October 3, 2010		4

	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended October 2, 2011 and October 3, 2010		5

	Notes to Condensed Consolidated Financial Statements		6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		25

Item 3.	Quantitative and Qualitative Disclosures about Market Risk		39

Item 4.	Controls and Procedures		40

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings		41

Item 1A.	Risk Factors		41

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		42

Item 6.	Exhibits		43

PART I

Item 1:

Financial Statements

TERADYNE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)


	October 2, 2011			December 31, 2010
	(in thousands, except per share amounts)
ASSETS
Current assets:
Cash and cash equivalents	$	1,095,163		$	397,737
Marketable securities		96,536			409,061
Accounts receivable, net of allowance for doubtful accounts of $4,106 and $3,752 at October 2, 2011 and December 31, 2010, respectively		143,523			168,756
Inventories:
Parts		91,934			78,109
Assemblies in process		23,403			16,013
Finished goods		18,002			22,719

		133,339			116,841
Deferred tax assets		23,176			22,730
Prepayments and other current assets		64,087			52,780
Current assets from discontinued operations		—			8,713

Total current assets		1,555,824			1,176,618
Property, plant and equipment, at cost		800,959			773,374
Less: accumulated depreciation		568,383			542,266

Net property, plant and equipment		232,576			231,108
Long-term marketable securities		40,712			248,696
Retirement plan assets		14,684			13,981
Intangible assets, net		101,604			122,941
Other assets		17,277			16,542
Long-term assets from discontinued operations		—			469

Total assets	$	1,962,677		$	1,810,355

LIABILITIES
Current liabilities:
Accounts payable	$	77,768		$	81,142
Accrued employees’ compensation and withholdings		75,495			105,374
Deferred revenue and customer advances		79,464			105,568
Other accrued liabilities		52,554			57,145
Accrued income taxes		5,135			8,465
Current debt		2,605			2,450
Current liabilities from discontinued operations		—			3,560

Total current liabilities		293,021			363,704
Long-term deferred revenue and customer advances		39,358			71,558
Retirement plan liabilities		74,718			72,071
Deferred tax liabilities		9,946			9,849
Long-term other accrued liabilities		18,908			19,448
Long-term debt		156,839			150,182
Long-term liabilities of discontinued operations		—			1,355

Total liabilities		592,790			688,167

Commitments and contingencies (Note O)

SHAREHOLDERS’ EQUITY

Common stock, $0.125 par value, 1,000,000 shares authorized, 184,122 shares and 182,035 shares issued and outstanding at October 2, 2011 and December 31, 2010, respectively		23,015			22,754
Additional paid-in capital		1,283,266			1,269,526
Accumulated other comprehensive loss		(122,925	)		(128,216	)
Retained earnings (accumulated deficit)		186,531			(41,876	)

Total shareholders’ equity		1,369,887			1,122,188

Total liabilities and shareholders’ equity	$	1,962,677		$	1,810,355

The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s

Annual Report on Form 10-K for the year ended December 31, 2010, are an integral part of the condensed

consolidated financial statements.

TERADYNE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


	For the Three Months Ended						For the Nine Months Ended
	October 2, 2011			October 3, 2010			October 2, 2011			October 3, 2010
	(in thousands, except per share amounts)
Net revenues:
Products	$	274,944		$	432,030		$	931,979		$	1,082,250
Services		69,445			59,361			200,090			173,750

Total net revenues		344,389			491,391			1,132,069			1,256,000
Cost of revenues:
Cost of products		138,617			188,758			451,975			474,052
Cost of services		35,927			30,834			102,754			89,371

Total cost of revenues		174,544			219,592			554,729			563,423

Gross profit		169,845			271,799			577,340			692,577
Operating expenses:
Engineering and development		46,799			49,048			142,169			146,326
Selling and administrative		55,304			60,560			171,014			172,977
Acquired intangible asset amortization		6,754			7,291			21,336			21,959
Restructuring and other, net		1,465			(1,977	)		3,157			(703	)

Total operating expenses		110,322			114,922			337,676			340,559

Income from operations		59,523			156,877			239,664			352,018
Interest income		3,049			1,466			5,739			5,989
Interest expense and other		(6,068	)		(6,033	)		(17,560	)		(19,695	)

Income from continuing operations before income taxes		56,504			152,310			227,843			338,312
Income tax provision		1,759			6,606			15,084			20,909

Income from continuing operations		54,745			145,704			212,759			317,403
Income from discontinued operations before income taxes		—			1,706			1,278			2,326
Income tax provision (benefit)		—			70			(267	)		140

Income from discontinued operations		—			1,636			1,545			2,186
Gain on disposal of discontinued operations (net of income tax of $0, $0, $4,578, $0, respectively)		—			—			24,371			—

Net income	$	54,745		$	147,340		$	238,675		$	319,589

Income per common share from continuing operations:
Basic	$	0.30		$	0.80		$	1.15		$	1.77

Diluted	$	0.25		$	0.65		$	0.93		$	1.44

Net income per common share:
Basic	$	0.30		$	0.81		$	1.29		$	1.78

Diluted	$	0.25		$	0.66		$	1.05		$	1.45

Weighted average common share—basic		185,102			181,239			185,063			179,365

Weighted average common share—diluted		221,892			229,389			228,141			229,069

The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s

Annual Report on Form 10-K for the year ended December 31, 2010, are an integral part of the condensed

consolidated financial statements.

TERADYNE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	For the Nine Months Ended
	October 2, 2011			October 3, 2010
	(in thousands)
Cash flows from operating activities:
Net income	$	238,675		$	319,589
Less: income from discontinued operations		1,545			2,186
Less: gain on disposal of discontinued operations		24,371			—

Income from continuing operations		212,759			317,403
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:
Depreciation		38,426			39,469
Amortization		37,547			34,610
Stock-based compensation		22,514			22,758
Provision for excess and obsolete inventory		10,756			5,181
Other		1,379			1,852
Changes in operating assets and liabilities, net of businesses sold:
Accounts receivable		25,233			(181,052	)
Inventories		(1,034	)		9,696
Prepayments and other assets		(13,553	)		1,031
Deferred revenue and customer advances		(58,304	)		76,020
Accounts payable and accrued expenses		(47,483	)		95,289
Retirement plan contributions		(6,393	)		(50,849	)
Accrued income taxes		(3,064	)		14,625

Net cash provided by operating activities from continuing operations		218,783			386,033
Net cash (used for) provided by operating activities from discontinued operations		(4,225	)		3,757

Net cash provided by operating activities		214,558			389,790
Cash flows from investing activities:
Purchases of property, plant and equipment		(66,623	)		(53,959	)
Purchases of available-for-sale marketable securities		(593,261	)		(478,260	)
Proceeds from sales and maturities of available-for-sale marketable securities		1,112,855			94,846
Proceeds from sales of trading marketable securities		—			23,750
Proceeds from life insurance		—			1,091

Net cash provided by (used for) investing activities from continuing operations		452,971			(412,532	)
Net cash provided by investing activities from discontinued operations		39,062			—

Net cash provided by (used for) investing activities		492,033			(412,532	)
Cash flows from financing activities:
Issuance of common stock under employee stock option and stock purchase plans		17,216			42,225
Payments of long-term debt		(2,518	)		(2,305	)
Repurchase of common stock		(23,863	)		—

Net cash (used for) provided by financing activities		(9,165	)		39,920

Increase in cash and cash equivalents		697,426			17,178
Cash and cash equivalents at beginning of period		397,737			416,737

Cash and cash equivalents at end of period	$	1,095,163		$	433,915

The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s

Annual Report on Form 10-K for the year ended December 31, 2010, are an integral part of the condensed

consolidated financial statements.

TERADYNE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

A. The Company

Teradyne, Inc. (“Teradyne”) is a leading global supplier of automatic test equipment. Teradyne’s automatic test equipment products and services include:

•

semiconductor test (“Semiconductor Test”) systems; and

•

military/aerospace (“Mil/Aero”) test instrumentation and systems, hard disk drive test (“HDD”) systems, and circuit-board test and inspection (“Commercial Board Test”) systems (collectively these products represent “Systems Test Group”).

B. Accounting Policies

Basis of Presentation

The condensed consolidated interim financial statements include the accounts of Teradyne and its subsidiaries. All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair presentation of such interim financial statements. Certain prior year’s amounts were reclassified to conform to the current year presentation. The December 31, 2010 condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.

The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in Teradyne’s Annual Report on Form 10-K, filed with the SEC on March 1, 2011 for the year ended December 31, 2010.

On March 21, 2011, Teradyne completed the sale of Diagnostic Solutions, its automotive diagnostic and test business unit. The results of operations of Diagnostic Solutions as well as balance sheet and cash flow amounts pertaining to this business have been classified as discontinued operations in the condensed consolidated financial statements (see Note D “Discontinued Operations”).

Preparation of Financial Statements

The preparation of consolidated financial statements requires management to make estimates and judgments that affect the amounts reported in the financial statements. Actual results may differ significantly from these estimates.

Net Income (Loss) per Common Share

Basic net income (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Except where the result would be antidilutive, diluted net income (loss) per common share is calculated by dividing net income (loss) by the sum of the weighted average number of common shares plus common stock equivalents, if applicable.

Prior to the fourth quarter of 2010, net income for diluted net income (loss) per share includes an impact of convertible notes that represents interest expense that would have not been recorded if the notes converted at the beginning of the period. Dilutive potential common shares include incremental shares from assumed conversion of the convertible notes and the convertible notes hedge warrant shares. Incremental shares from assumed

conversion of the convertible notes are calculated using the difference between the average Teradyne stock price for the period and the conversion price of $5.48, multiplied by the 34.7 million shares that will be issued upon conversion. The result of this calculation, representing total intrinsic value of the convertible debt, is divided by the average Teradyne stock price for the period. Convertible notes hedge warrant shares are calculated using the difference between the average Teradyne stock price for the period and the warrant price of $7.67, multiplied by the 34.7 million shares that will be issued upon conversion. The result of this calculation, representing total intrinsic value of the warrant, is divided by the average Teradyne stock price for the period.

With respect to the Teradyne’s convertible debt, Teradyne intends to settle its conversion spread (i.e., the intrinsic value of the embedded option feature contained in the convertible debt) in shares. Teradyne accounts for its conversion spread using the treasury stock method. In the fourth quarter of 2010, Teradyne determined that it had the ability and intent to settle the principal amount of the convertible debt in cash; accordingly as of the fourth quarter of 2010, the principal amount has been excluded from the determination of diluted earnings per share.

C. Recently Issued Accounting Pronouncements

In March 2010, FASB issued an Accounting Standards Update (“ASU”) 2010-17, “Milestone Method of Revenue Recognition”, to Accounting Standards Codification (“ASC”) 605, “Revenue Recognition.” The guidance in this consensus allows the milestone method as an acceptable revenue recognition methodology when an arrangement includes substantive milestones. The guidance provides a definition of substantive milestone and should be applied regardless of whether the arrangement includes single or multiple deliverables or units of accounting. The scope of this consensus is limited to the transactions involving milestones relating to research and development deliverables. The guidance includes enhanced disclosure requirements about each arrangement, individual milestones and related contingent consideration, information about substantive milestones and factors considered in the determination. The consensus is effective prospectively to milestones achieved in fiscal years, and interim periods within those years, after June 15, 2010. Teradyne adopted this final consensus prospectively in January 2011. This adoption had no material impact on Teradyne’s financial position or results of operations.

In May 2011, the FASB issued ASU No. 2011-04, “Fair Value Measurement.” This ASU clarifies the concepts related to highest and best use and valuation premise, blockage factors and other premiums and discounts, the fair value measurement of financial instruments held in a portfolio and of those instruments classified as a component of shareowners’ equity. The guidance includes enhanced disclosure requirements about recurring Level 3 fair value measurements, the use of nonfinancial assets, and the level in the fair value hierarchy of assets and liabilities not recorded at fair value. The provisions of this ASU are effective prospectively for interim and annual periods beginning on or after December 15, 2011. Early application is prohibited. This ASU requires changes in presentation only and Teradyne does not expect it will have a material impact on its consolidated financial statements.

In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income.” This ASU intends to enhance comparability and transparency of other comprehensive income components. The guidance provides an option to present total comprehensive income, the components of net income and the components of other comprehensive income in a single continuous statement or two separate but consecutive statements. This ASU eliminates the option to present other comprehensive income components as part of the statement of changes in shareowners’ equity. The provisions of this ASU will be applied retrospectively for interim and annual periods beginning after December 15, 2011. Early application is permitted. This ASU requires changes in presentation only and Teradyne does not expect it will have a material impact on its consolidated financial statements.

new guidance is effective for goodwill impairment tests performed in interim and annual periods for fiscal years beginning after December 15, 2011, with early adoption permitted. Teradyne does not expect this guidance to have a material impact on its consolidated financial statements.

D. Discontinued Operations

On March 21, 2011, Teradyne completed the sale of its Diagnostic Solutions business unit, which was included in the Systems Test Group segment, to SPX Corporation for $40.2 million in cash. Teradyne sold this business as its growth potential as a stand-alone business within Teradyne was significantly less than if it was part of a larger automotive supplier. The financial information for Diagnostic Solutions has been reclassified to discontinued operations for all periods presented. Net revenues and income from discontinued operations for the three and nine months ended October 2, 2011 and October 3, 2010 were as follows:


	For the Three Months Ended				For the Nine Months Ended
	October 2, 2011		October 3, 2010		October 2, 2011		October 3, 2010
	(in thousands)
Net revenues	$	—	$	10,695	$	9,086	$	30,485

Income from discontinued operations before income taxes	$	—	$	1,706	$	1,278	$	2,326
Gain from disposal of discontinued operations before income taxes		—		—		28,949		—
Income tax provision		—		70		4,311		140

Income from discontinued operations	$	—	$	1,636	$	25,916	$	2,186

E. Financial Instruments and Derivatives

Financial Instruments

Teradyne uses the market and income approach to value its financial instruments and there was no change in valuation techniques used by Teradyne during the nine months ended October 2, 2011 and October 3, 2010. As defined in ASC 820-10, “Fair Value Measurements and Disclosures”, fair value is the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820-10 requires that assets and liabilities are carried at fair value and are classified in one of the following three categories:

Level 1: Quoted prices in active markets for identical assets as of the reporting date.

Level 2: Inputs other than Level 1, that are observable either directly or indirectly as of the reporting date. For example, a common approach for valuing fixed income securities is the use of matrix pricing. Matrix pricing is a mathematical technique used to value securities by relying on the securities’ relationship to other benchmark quoted prices.

Level 3: Unobservable inputs that are not supported by market data. Unobservable inputs are developed based on the best information available, which might include Teradyne’s own data.

For the right to sell the auction rate securities, held by Teradyne, back to UBS (“UBS Put”), Teradyne elected fair value treatment under ASC 825-10, “Financial Instruments.” The UBS Put was the only instrument of this nature or type that Teradyne held and for which Teradyne has elected the fair value option under ASC 825-10. The UBS Put was exercised in June 2010.

During the nine months ended October 2, 2011 and October 3, 2010, there were no significant transfers in and out of Level 1 and Level 2.

The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of October 2, 2011 and December 31, 2010.


	October 2, 2011
	Quoted Prices in Active Markets for Identical Instruments (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
	(in thousands)
Assets
Available for sale securities:
Money market funds	$	840,816	$	—	$	—	$	840,816
Corporate debt securities		—		41,436		—		41,436
Commercial paper		—		37,774		—		37,774
U.S. government agency securities		—		34,046		—		34,046
U.S. Treasury securities		10,997		—		—		10,997
Equity and debt mutual funds		7,554		—		—		7,554
Certificates of deposit and time deposits		—		5,154		—		5,154
Non-U.S. government securities		287		—		—		287

Total		859,654		118,410		—		978,064
Derivatives		—		109		—		109

Total	$	859,654	$	118,519	$	—	$	978,173

Reported as follows:


	(Level 1)		(Level 2)		(Level 3)		Total
	(in thousands)
Assets
Cash and cash equivalents	$	840,816	$	—	$	—	$	840,816
Marketable securities		9,040		87,496		—		96,536
Long-term marketable securities		9,798		30,914		—		40,712
Prepayments and other current assets		—		109		—		109

	$	859,654	$	118,519	$	—	$	978,173


	December 31, 2010
	Quoted Prices in Active Markets for Identical Instruments (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
	(in thousands)
Assets
Available for sale securities:
U.S. government agency securities	$	—	$	341,510	$	—	$	341,510
Money market funds		238,607		—		—		238,607
U.S. Treasury securities		138,707		—		—		138,707
Commercial paper		—		103,448		—		103,448
Corporate debt securities		—		92,578		—		92,578
Certificates of deposit and time deposits		—		11,076		—		11,076
Equity and debt mutual funds		8,003		—		—		8,003
Non-U.S. government securities		278		—		—		278

Total	$	385,595	$	548,612	$	—	$	934,207

Liabilities
Derivatives	$	—	$	632	$	—	$	632

Total	$	—	$	632	$	—	$	632

Reported as follows:


	(Level 1)		(Level 2)		(Level 3)		Total
	(in thousands)
Assets
Cash and cash equivalents	$	238,607	$	37,843	$	—	$	276,450
Marketable securities		62,294		346,767		—		409,061
Long-term marketable securities		84,694		164,002		—		248,696

	$	385,595	$	548,612	$	—	$	934,207

Liabilities
Other accrued liabilities	$	—	$	632	$	—	$	632

The following table represents changes in the fair value of Level 3 financial assets:


	For the Three Months Ended
	October 2, 2011		October 3, 2010
	Long-Term Auction Rate Securities		Long-Term Auction Rate Securities
	(in thousands)
Balance at beginning of period	$	—	$	2,836
Sale of auction rate securities		—		(50	)

Balance at end of period	$	—	$	2,786


	For the Nine Months Ended
	October 2, 2011				October 3, 2010
	Long-Term Auction Rate Securities		UBS Put		Long-Term Auction Rate Securities			UBS Put
	(in thousands)
Balance at beginning of period	$	—	$	—	$	23,649		$	2,830
Sale of auction rate securities and exercise of UBS Put		—		—		(21,063	)		(2,687	)
Change in unrealized gain included in interest income		—		—		200			—
Change in unrealized loss included in interest expense and other		—		—		—			(143	)

Balance at end of period	$	—	$	—	$	2,786		$	—

During the three and nine months ended October 2, 2011, Teradyne recorded a net gain of $2.2 million from sales of marketable securities. During the nine months ended October 3, 2010, Teradyne recorded a net loss of $0.4 million from sales of marketable securities and exercise of UBS Put.

Realized losses from sales of marketable securities, decreases in auction rate securities fair value and other-than-temporary impairment losses are included in interest expense and other. Realized gains from sales of marketable securities and increases in auction rate securities fair value are included in interest income.

The carrying amounts and fair values of financial instruments at October 2, 2011 and December 31, 2010 were as follows:


	October 2, 2011				December 31, 2010
	Carrying Value		Fair Value		Carrying Value		Fair Value
	(in thousands)
Cash equivalents	$	840,816	$	840,816	$	276,450	$	276,450
Marketable securities		137,248		137,248		657,757		657,757
Convertible debt(1)		152,933		402,800		144,059		506,350
Japan loan		6,511		6,511		8,573		8,573

(1)	The carrying value represents the bifurcated debt component only, while the fair value is based on quoted market prices for the convertible note which includes the equity conversion feature.

The fair values of cash, accounts receivable, net and accounts payable approximate the carrying amount due to the short-term maturities of these instruments.

The following table summarizes available-for-sale marketable securities which are recorded at fair value:


	October 2, 2011
	Available-for-Sale									Fair Market Value of Investments with Unrealized Losses
	Cost		Unrealized Gain		Unrealized (Loss)			Fair Market Value		Fair Market Value of Investments with Unrealized Losses
	(in thousands)
Money market funds	$	840,816	$	—	$	—		$	840,816	$	—
Corporate debt securities		39,850		1,756		(170	)		41,436		19,535
Commercial paper		37,776		3		(5	)		37,774		17,980
U.S. government agency securities		33,888		158		—			34,046		—
U.S. Treasury securities		10,920		77		—			10,997		—
Equity and debt mutual funds		7,511		330		(287	)		7,554		4,239
Certificates of deposit and time deposits		5,154		—		—			5,154		—
Non-U.S. government securities		287		—		—			287		—

	$	976,202	$	2,324	$	(462	)	$	978,064	$	41,754

Reported as follows:


	Cost		Unrealized Gain		Unrealized (Loss)			Fair Market Value		Fair Market Value of Investments with Unrealized Losses
	(in thousands)
Cash and cash equivalents	$	840,816	$	—	$	—		$	840,816	$	—
Marketable securities		96,529		35		(28	)		96,536		34,497
Long-term marketable securities		38,857		2,289		(434	)		40,712		7,257

	$	976,202	$	2,324	$	(462	)	$	978,064	$	41,754


	December 31, 2010
	Available-for-Sale									Fair Market Value of Investments with Unrealized Losses
	Cost		Unrealized Gain		Unrealized (Loss)			Fair Market Value		Fair Market Value of Investments with Unrealized Losses
	(in thousands)
U.S. government agency securities	$	341,349	$	334	$	(173	)	$	341,510	$	97,542
Money market funds		238,607		—		—			238,607		—
U.S. Treasury securities		138,354		360		(7	)		138,707		10,030
Commercial paper		103,472		1		(25	)		103,448		33,210
Corporate debt securities		92,464		170		(56	)		92,578		43,434
Certificates of deposit and time deposits		11,068		8		—			11,076		—
Equity and debt mutual funds		7,056		1,378		(431	)		8,003		1,088
Non-U.S. government securities		261		17		—			278		—

	$	932,631	$	2,268	$	(692	)	$	934,207	$	185,304

Reported as follows:


	Cost		Unrealized Gain		Unrealized (Loss)			Fair Market Value		Fair Market Value of Investments with Unrealized Losses
	(in thousands)
Cash and cash equivalents	$	276,447	$	3	$	—		$	276,450	$	—
Marketable securities		408,934		178		(51	)		409,061		103,761
Long-term marketable securities		247,250		2,087		(641	)		248,696		81,543

	$	932,631	$	2,268	$	(692	)	$	934,207	$	185,304

On a quarterly basis, Teradyne reviews its investments to identify and evaluate those that have an indication of a potential other-than-temporary impairment. Factors considered in determining whether a loss is other-than-temporary include:

•

The length of time and the extent to which the market value has been less than cost;

•

The financial condition and near-term prospects of the issuer; and

•

The intent and ability to retain the investment in the issuer for a period of time sufficient to allow for any anticipated recovery in market value.

As of October 2, 2011, the fair market value of investments with unrealized losses totaled $41.8 million. Of this value, $0.1 million had unrealized losses greater than one year and $41.7 million had unrealized losses less than one year. As of December 31, 2010, the fair market value of investments with unrealized losses totaled $185.3 million. Of this value, $5.0 million had unrealized losses greater than one year and $180.3 million had unrealized losses less than one year.

Derivatives

Teradyne conducts business in a number of foreign countries, with certain transactions denominated in local currencies. The purpose of Teradyne’s foreign currency management is to minimize the effect of exchange rate fluctuations on certain foreign currency denominated net monetary assets. Teradyne does not use derivative financial instruments for trading or speculative purposes.

To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings, and is used to offset the change in fair value of the monetary assets and liabilities denominated in foreign currencies.

The notional amount of foreign exchange contracts hedging monetary assets and liabilities denominated in foreign currencies was $72.2 million and $82.6 million at October 2, 2011 and December 31, 2010, respectively.

The following table summarizes the fair value of derivative instruments at October 2, 2011 and December 31, 2010.


	Balance Sheet Location	October 2, 2011		December 31, 2010
		(in thousands)
Derivatives not designated as hedging instruments:
Foreign exchange contracts	Prepayments and other current assets	$	109	$	—
Foreign exchange contracts	Other accrued liabilities		—		632

		$	109	$	632

The following table summarizes the effect of derivative instruments in the statement of operations recognized during the three and nine months ended October 2, 2011 and October 3, 2010. The table does not reflect the corresponding gains (losses) from the remeasurement of the monetary assets and liabilities denominated in foreign currencies.


	Location of (Losses) Gains Recognized in Statement of Operations		For the Three Months Ended					For the Nine Months Ended
			October 2, 2011			October 3, 2010		October 2, 2011			October 3, 2010
			(in thousands)
Derivatives not designated as hedging instruments:
Foreign exchange contracts		Interest expense and other	$	(1,429	)	$	209	$	(858	)	$	(1,054	)

			$	(1,429	)	$	209	$	(858	)	$	(1,054	)

See Note F “Debt” regarding derivatives related to convertible senior notes.

F. Debt

Loan Agreement

On March 31, 2009, Teradyne K.K., Teradyne’s wholly-owned subsidiary in Japan, entered into a loan agreement with a local bank in Japan to borrow approximately $10.0 million. The loan has a term of 5 years and a fixed interest rate of 0.81%. Approximately $6.0 million of the loan is collateralized by a real estate mortgage on Teradyne K.K.’s building and land in Kumamoto, Japan and approximately $4.0 million is unsecured. Teradyne, Inc. has guaranteed payment of the loan obligation. The loan is amortized over the term of the loan with semiannual principal payments of approximately $1.0 million payable on September 30 and March 30 each year. At October 2, 2011, approximately $2.6 million of the outstanding loan principal is included in current debt and approximately $3.9 million is classified as long-term debt.

Convertible Senior Notes

In April 2009, Teradyne issued 4.50% convertible senior notes (the “Notes”) at an aggregate principal amount of $190 million. The Notes will mature on March 15, 2014, unless earlier repurchased by Teradyne or converted. The Notes are senior unsecured obligations and rank equally with all of Teradyne’s existing and future senior debt and senior to any of Teradyne’s subordinated debt.

The Notes may be converted, under certain circumstances and during certain periods, at an initial conversion rate of approximately 182.65 shares of Teradyne’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $5.48, a 25% conversion premium based on the last reported sale price of $4.38 per share of Teradyne’s common stock on March 31, 2009. The conversion rate is subject to adjustment in certain circumstances.

During the three months ended October 2, 2011, the following circumstance that allows holders to convert their Notes at their option prior to December 15, 2013 occurred: the last reported sale price of Teradyne’s common stock for 20 or more trading days in a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter exceeded 130% of the conversion price in effect on the last trading day of the immediately preceding calendar quarter. As of November 14, 2011, no holders have exercised their option to convert their Notes.

Concurrently with the offering of the Notes, Teradyne entered into a convertible note hedge transaction with a strike price equal to the initial conversion price of the Notes, or approximately $5.48. The convertible note hedge allows Teradyne to receive shares of its common stock and/or cash related to the excess conversion value that it would pay to the holders of the Notes upon conversion. The convertible note hedges will cover, subject to customary antidilution adjustments, approximately 34,703,196 shares of Teradyne’s common stock. Teradyne paid approximately $64.6 million for the convertible note hedges.

Separately, Teradyne entered into a warrant transaction with a strike price of approximately $7.67 per share, which is 75% higher than the closing price of Teradyne’s common stock on March 31, 2009.

The convertible note hedge and warrant transaction will generally have the effect of increasing the conversion price of the Notes to approximately $7.67 per share of Teradyne’s common stock, representing a 75% conversion premium based upon the closing price of Teradyne’s common stock on March 31, 2009.

The Notes are classified as long-term debt in the balance sheet at October 2, 2011 and December 31, 2010. The tables below represent the components of Teradyne’s convertible senior notes:


	October 2, 2011		December 31, 2010
	(in thousands)
Debt principal	$	190,000	$	190,000
Unamortized debt discount		37,067		45,941

Net carrying amount of the convertible debt	$	152,933	$	144,059


	For the Three Months Ended				For the Nine Months Ended
	October 2, 2011		October 3, 2010		October 2, 2011		October 3, 2010
	(in thousands)
Contractual interest expense	$	2,114	$	2,138	$	6,460	$	6,509
Amortization of the discount component and debt issue fees		3,263		2,783		9,484		8,263

Total interest expense on the convertible debt	$	5,377	$	4,921	$	15,944	$	14,772

As of October 2, 2011, the unamortized discount was $37.1 million, which will be amortized over approximately 2.5 years, and the carrying amount of the equity component was $63.4 million. As of October 2, 2011, the conversion rate was equal to the initial conversion price of approximately $5.48 per share and the if-converted value of the Notes was $382.1 million.

G. Deferred Revenue and Customer Advances

Deferred revenue and customer advances consist of the following and are included in short and long-term deferred revenue and customer advances.


	October 2, 2011		December 31, 2010
	(in thousands)
Customer advances	$	79,299	$	132,559
Maintenance, training and extended warranty		31,320		36,626
Undelivered elements		7,351		5,858
Acceptance		852		2,083

Total deferred revenue and customer advances	$	118,822	$	177,126

H. Product Warranty

Teradyne generally provides a one-year warranty on its products commencing upon installation or shipment. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based on historical experience. Related costs are charged to the warranty accrual as incurred. The balance below is included in other accrued liabilities.


	For the Three Months Ended						For the Nine Months Ended
	October 2, 2011			October 3, 2010			October 2, 2011			October 3, 2010
	(in thousands)
Balance at beginning of period	$	9,262		$	10,636		$	9,886		$	6,435
Accruals for warranties issued during the period		3,502			5,212			11,056			14,069
Adjustments related to pre-existing warranties		(491	)		(391	)		(2,563	)		(37	)
Settlements made during the period		(3,220	)		(3,464	)		(9,326	)		(8,474	)

Balance at end of period	$	9,053		$	11,993		$	9,053		$	11,993

When Teradyne receives revenue for extended warranties beyond one year, it is deferred and recognized on a straight-line basis over the contract period. Related costs are expensed as incurred. The balance below is included in deferred revenue and customer advances and long-term other accrued liabilities.


	For the Three Months Ended						For the Nine Months Ended
	October 2, 2011			October 3, 2010			October 2, 2011			October 3, 2010
	(in thousands)
Balance at beginning of period	$	10,308		$	5,643		$	8,972		$	4,055
Deferral of new extended warranty revenue		1,324			2,193			5,123			5,408
Recognition of extended warranty deferred revenue		(2,194	)		(800	)		(4,657	)		(2,427	)

Balance at end of period	$	9,438		$	7,036		$	9,438		$	7,036

I. Stock-Based Compensation

During the nine months ended October 2, 2011, Teradyne granted service-based restricted stock units to employees, and service-based stock options and service and performance-based restricted stock units to executive officers. The total number of restricted stock units granted was 1.7 million at a weighted average grant date fair value of $16.20. Restricted stock units vest in equal installments over four years. The percentage level of performance satisfied for performance-based grants is assessed on or near the anniversary of the grant date and, in turn, that percentage level determines the number of performance-based restricted stock units available for vesting over the vesting period; portions of the performance-based grants not available for vesting are forfeited. The total number of stock options granted to executive officers was 0.1 million at a weighted average grant date fair value of $6.74. The stock options vest in equal installments over four years, and have a term of seven years from the date of grant.

During the nine months ended October 3, 2010, Teradyne granted service-based restricted stock units to employees, and service and performance-based restricted stock units and stock options to executive officers. The total number of restricted stock units granted was 2.6 million at a weighted average grant date fair value of $9.42. The total number of stock options granted was 0.3 million at a weighted average grant date fair value of $4.10. Restricted stock units and stock options vest in equal installments over four years. The stock options have a term of seven years from the date of grant.

The fair value of stock options was estimated using the Black-Scholes option-pricing model with the following assumptions:


	For the Nine Months Ended
	October 2, 2011			October 3, 2010
Expected life (years)		4.00			4.75
Interest rate		1.5	%		2.4	%
Volatility-historical		52.1	%		48.8	%
Dividend yield		0.0	%		0.0	%

Teradyne determined the stock options’ expected life based upon historical exercise data for executive officers, the age of the executive officers and the terms of the stock option grant. Volatility was determined using historical volatility for a period equal to the expected life. The risk-free rate was determined using the U.S. Treasury yield curve in effect at the time of grant.

The weighted-average fair value of employee stock purchase rights granted in the first and last six months of 2011 was $3.66 and $4.01, respectively, and the first and last six months of 2010 was $3.05 and $2.77, respectively. The fair value of the employees’ purchase rights was estimated using the Black-Scholes option-pricing model with the following assumptions:


	For the Nine Months Ended
	October 2, 2011			October 3, 2010
Expected life (years)		0.5			0.5
Interest rate		0.14	%		0.20	%
Volatility-historical		41.0	%		48.0	%
Dividend yield		0.0	%		0.0	%

J. Comprehensive Income

Comprehensive income is calculated as follows:


	For the Three Months Ended					For the Nine Months Ended
	October 2, 2011			October 3, 2010		October 2, 2011			October 3, 2010
	(in thousands)
Net income	$	54,745		$	147,340	$	238,675		$	319,589
Foreign currency translation adjustment		—			264		2,266			(99	)
Unrealized (losses) gains on investments, net of tax of $0, $0, $0 and $0		(1,057	)		1,435		256			1,731
Actuarial (losses) gains arising during period, net of tax of $0, $293, $(5) and $1,540		(5	)		342		(4,206	)		17,929
Amortization included in net periodic pension and post-retirement costs:
Actuarial losses, net of tax of $11, $21, $30 and $109		2,226			1,333		6,681			4,040
Prior service costs, net of tax of $0, $0, $0 and $0		5			32		17			278
Settlement loss net of tax of $0, $0, $73 and $0		—			—		277			—

Comprehensive income	$	55,914		$	150,746	$	243,966		$	343,468

K. Intangible Assets

Amortizable intangible assets consist of the following and are included in intangible assets on the balance sheet:


	October 2, 2011
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Weighted Average Useful Life
	(in thousands)
Developed technology	$	121,055	$	78,406	$	42,649		6.1 years
Customer relationships and service and software maintenance contracts		91,271		40,671		50,600		8.6 years
Trade names and trademarks		14,840		6,485		8,355		11.5 years
Customer backlog		300		300		—		0.5 years

Total intangible assets	$	227,466	$	125,862	$	101,604		7.6 years


	December 31, 2010
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Weighted Average Useful Life
	(in thousands)
Developed technology	$	121,055	$	65,610	$	55,445		6.1 years
Customer relationships and service and software maintenance contracts		91,271		32,749		58,522		8.6 years
Trade names and trademarks		14,840		5,866		8,974		11.5 years
Customer backlog		300		300		—		0.5 years

Total intangible assets	$	227,466	$	104,525	$	122,941		7.6 years

Aggregate intangible asset amortization expense was $6.8 million and $21.3 million, respectively, for the three and nine months ended October 2, 2011 and $7.3 million and $22.0 million, respectively, for the three and nine months ended October 3, 2010. Estimated intangible asset amortization expense for each of the five succeeding fiscal years is as follows:


Year	Amount (in thousands)
2011 (remainder)	$	6,485
2012		25,732
2013		24,683
2014		21,598
2015		4,575

L. Net Income per Common Share

The following table sets forth the computation of basic and diluted net income per common share:


	For the Three Months Ended				For the Nine Months Ended
	October 2, 2011		October 3, 2010		October 2, 2011		October 3, 2010
	(in thousands, except per share amounts)
Income from continuing operations	$	54,745	$	145,704	$	212,759	$	317,403
Income from discontinued operations		—		1,636		1,545		2,186
Gain on disposal of discontinued operations		—		—		24,371		—

Net income for basic net income per share	$	54,745	$	147,340	$	238,675	$	319,589
Income impact of assumed conversion of convertible notes(1)		—		4,438		—		13,203

Net income for diluted net income per share	$	54,745	$	151,778	$	238,675	$	332,792

Weighted average common shares-basic		185,102		181,239		185,063		179,365
Effect of dilutive potential common shares:
Incremental shares from assumed conversion of convertible notes(2)		19,540		34,703		21,870		34,703
Convertible notes hedge warrant shares(3)		13,475		8,506		16,737		9,618
Restricted stock units		3,377		2,848		3,942		2,880
Stock options		346		2,044		454		2,439
Employee stock purchase rights		52		49		75		64

Dilutive potential common shares		36,790		48,150		43,078		49,704

Weighted average common shares-diluted		221,892		229,389		228,141		229,069

Net income per common share-basic
Continuing operations	$	0.30	$	0.80	$	1.15	$	1.77
Discontinued operations		—		0.01		0.14		0.01

	$	0.30	$	0.81	$	1.29	$	1.78

Net income per common share-diluted
Continuing operations	$	0.25	$	0.65	$	0.93	$	1.44
Discontinued operations		—		0.01		0.12		0.01

	$	0.25	$	0.66	$	1.05	$	1.45

(1)	Income impact of convertible notes for the three and nine months ended October 3, 2010 represents interest expense that would have not been recorded if the notes converted at the beginning of the period.

(2)

Incremental shares from assumed conversion of the convertible notes for the three and nine months ended October 2, 2011 are calculated using the difference between the average Teradyne stock price for the period and the conversion price of $5.48, multiplied by the 34.7 million shares that will be issued upon conversion. The result of this calculation, representing total intrinsic value of the convertible debt, is divided by the average Teradyne stock price for the period. For the three and nine months ended October 3, 2010, incremental shares from assumed conversion of the convertible notes represent the 34.7 million of shares that will be issued upon conversion.

(3)

Convertible notes hedge warrant shares for the three and nine months ended October 2, 2011 are calculated using the difference between the average Teradyne stock price for the period and the warrant price of $7.67, multiplied by the 34.7 million shares that will be issued upon conversion. The result of this calculation, representing total intrinsic value of the warrant, is divided by the average Teradyne stock price for the period.

The computation of diluted net income per common share for the three and nine months ended October 2, 2011 excludes the effect of the potential exercise of stock options to purchase approximately 0.5 million and 0.8 million shares and restricted stock units of 1.4 million and 0.5 million, respectively, because the effect would have been anti-dilutive.

The computation of diluted net income per common share for the three and nine months ended October 3, 2010 excludes the effect of the potential exercise of stock options to purchase approximately 4.4 million and 5.5 million shares and restricted stock units of 0.1 million and 0.1 million shares, respectively, because the effect would have been anti-dilutive.

With respect to the Teradyne’s convertible debt, Teradyne intends to settle its conversion spread (i.e., the intrinsic value of the embedded option feature contained in the convertible debt) in shares. Teradyne accounts for its conversion spread using the treasury stock method. In the fourth quarter of 2010, Teradyne determined that it had the ability and intent to settle the principal amount of the convertible debt in cash, accordingly as of the fourth quarter of 2010; the principal amount has been excluded from the determination of diluted earnings per share.

Teradyne’s call option on its common stock (convertible note hedge transaction) is excluded from the calculation of diluted shares because the effect would be anti-dilutive. See Note F “Debt” regarding convertible note hedge transaction.

M. Restructuring and Other, Net

Restructuring

In response to a downturn in the industry in 2008 and 2009, Teradyne initiated restructuring activities across all segments to reduce costs, principally through headcount reductions and facility consolidations. The tables below represent activity related to these actions. The remaining accrual for severance and benefits is reflected in the accrued employees’ compensation and withholdings account on the balance sheet and is expected to be paid by July 2012. The remaining accrual for lease payments on vacated facilities is reflected in the other accrued liabilities account and the long-term other accrued liabilities account and is expected to be paid over the lease terms, the latest of which expires in 2013. Teradyne expects to pay approximately $0.9 million against the lease accruals over the next twelve months. Teradyne’s future lease commitments are net of expected sublease income of $0.6 million as of October 2, 2011.


	Severance and Benefits			Facility Exit Costs			Total
	(in thousands)
*Pre-2010 Activities*
Balance at December 31, 2009	$	2,905		$	10,166		$	13,071
Change in estimate		240			(2,672	)		(2,432	)
Cash payments		(3,124	)		(4,193	)		(7,317	)

Balance at December 31, 2010		21			3,301			3,322
Change in estimate		—			(432	)		(432	)
Cash payments		(21	)		(242	)		(263	)

Balance at April 3, 2011		—			2,627			2,627
Cash payments		—			(301	)		(301	)

Balance at July 3, 2011		—			2,326			2,326
Cash payments		—			(211	)		(211	)

Balance at October 2, 2011	$	—		$	2,115		$	2,115


	Severance and Benefits			Facility Exit Costs		Total
	(in thousands)
*2010 Activities*
Q1 2010 Activity:
Provision	$	405		$	—	$	405
Cash payments		(405	)		—		(405	)

Balance at December 31, 2010	$	—		$	—	$	—

Q2 2010 Activity:
Provision	$	890		$	—	$	890
Cash payments		(402	)		—		(402	)

Balance at December 31, 2010		488			—		488
Provision		202			—		202
Cash payments		(690	)		—		(690	)

Balance at April 3, 2011	$	—		$	—	$	—

Q3 2010 Activity:
Provision	$	382		$	—	$	382
Cash payments		(72	)		—		(72	)
Other		(184	)		—		(184	)

Balance at December 31, 2010		126			—		126
Change in estimate		(47	)		—		(47	)
Cash payments		(79	)		—		(79	)

Balance at April 3, 2011	$	—		$	—	$	—

Q4 2010 Activity:
Provision	$	98		$	—	$	98

Balance at December 31, 2010		98			—		98
Provision		117			—		117
Cash payments		(215	)		—		(215	)

Balance at April 3, 2011	$	—		$	—	$	—

*2011 Activity*
Q1 2011 Activity:
Provision	$	572		$	—	$	572
Cash payments		(241	)		—		(241	)

Balance at April 3, 2011		331			—		331
Cash payments		(154	)		—		(154	)

Balance at July 3, 2011		177			—		177
Change in estimate		(9	)		—		(9	)
Cash payments		(43	)		—		(43	)

Balance at October 2, 2011	$	125		$	—	$	125

Q2 2011 Activity:
Provision	$	344		$	—	$	344

Balance at July 3, 2011		344			—		344
Cash payments		(57	)		—		(57	)

Balance at October 2, 2011	$	287		$	—	$	287

Balance at October 2, 2011	$	412		$	2,115	$	2,527

During the nine months ended October 2, 2011, Teradyne recorded the following restructuring charges:

Q2 2011 Action:

•

$0.3 million of severance charges related to headcount reductions of 2 people in Semiconductor Test segment.

Q1 2011 Action:

•

$0.6 million of severance charges related to headcount reductions of 5 people in Semiconductor Test segment.

Pre-2010 Actions:

•

$(0.4) million related to changes in the estimated exit costs related to the Westford, MA and Poway, CA facilities in System Test Group segment, and the North Reading, MA facility across both segments.

Q2 2010 Actions:

•

$0.2 million related to a change in the estimated severance benefits related to headcount reduction activities across both segments.

Q3 2010 Actions:

•

$0.1 million related to a change in the estimated severance benefits related to headcount reduction activities across both segments.

During the nine months ended October 3, 2010, Teradyne recorded the following restructuring charges:

Q3 2010 Actions:

•

$0.4 million of severance charges related to headcount reductions of 10 people in Systems Test Group.

Q2 2010 Actions:

•

$0.7 million of severance charges related to headcount reductions of approximately 6 people in Systems Test Group.

Q1 2010 Actions:

•

$0.4 million of severance charges related to headcount reductions of 4 people in Semiconductor Test.

Q2 2009 Actions:

•

$0.2 million related to a change in the estimated severance benefits related to headcount reduction activities across both segments.

Pre-2009 Actions:

•

$(2.4) million credit related to the early exit of previously impaired leased facilities in Westford, Massachusetts.

Other

During the nine months ended October 2, 2011, Teradyne recorded $1.3 million of acquisition costs, and $0.9 million charge related to a non-U.S. pension settlement.

N. Retirement Plans

Defined Benefit Pension Plans

Teradyne has defined benefit pension plans covering a portion of domestic employees and employees of certain non-U.S. subsidiaries. Benefits under these plans are based on employees’ years of service and compensation. Teradyne’s funding policy is to make contributions to these plans in accordance with local laws

and to the extent that such contributions are tax deductible. The assets of these plans consist primarily of equity and fixed income securities. In addition, Teradyne has foreign unfunded defined benefit pension plans and an unfunded supplemental executive defined benefit plan in the United States to provide retirement benefits in excess of levels allowed by the Employment Retirement Income Security Act and the Internal Revenue Code.

Components of net periodic pension cost for all plans were as follows:


	For the Three Months Ended						For the Nine Months Ended
	October 2, 2011			October 3, 2010			October 2, 2011			October 3, 2010
	(in thousands)
Service cost	$	656		$	760		$	2,117		$	2,687
Interest cost		4,380			4,410			13,180			13,192
Expected return on plan assets		(4,178	)		(5,020	)		(12,545	)		(15,153	)
Amortization of unrecognized:
Prior service cost		155			182			466			545
Net loss		2,192			1,325			6,576			4,091
Settlement		—			442			850			442

Total net periodic pension cost	$	3,205		$	2,099		$	10,644		$	5,804

In the nine months ended October 2, 2011, Teradyne contributed $5.1 million primarily to its foreign pension plans.

Post-Retirement Benefit Plans

In addition to receiving pension benefits, U.S. Teradyne employees who meet early retirement eligibility requirements as of their termination dates may participate in Teradyne’s Welfare Plan, which includes death, and medical and dental benefits up to age 65. Death benefits provide a fixed sum to retirees’ survivors and are available to all retirees. Substantially all of Teradyne’s current U.S. employees could become eligible for these benefits, and the existing benefit obligation relates primarily to those employees.

Components of net periodic post-retirement cost were as follows:


	For the Three Months Ended						For the Nine Months Ended
	October 2, 2011			October 3, 2010			October 2, 2011			October 3, 2010
	(in thousands)
Service cost	$	15		$	15		$	44		$	42
Interest cost		135			138			404			530
Amortization of unrecognized:
Prior service benefit		(150	)		(150	)		(449	)		(267	)
Net loss		45			29			135			58

Total net periodic post-retirement cost	$	45		$	32		$	134		$	363

O. Commitments and Contingencies

Purchase Commitments

As of October 2, 2011, Teradyne had entered into purchase commitments for certain components and materials. The purchase commitments aggregate to approximately $132.2 million, of which $127.3 million is for less than one year.

Legal Claims

Teradyne is subject to various legal proceedings and claims which have arisen in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on Teradyne’s results of operations, financial condition or cash flows.

P. Segment Information

Teradyne has two operating segments (Semiconductor Test and Systems Test Group) which are its reportable segments. Each operating segment has a segment manager who is directly accountable to and maintains regular contact with Teradyne’s chief operating decision maker (Teradyne’s chief executive officer) to discuss operating activities, financial results, forecasts, and plans for the segment. The Semiconductor Test segment includes operations related to the design, manufacturing and marketing of semiconductor test products and services. The Systems Test Group segment includes operations related to the design, manufacturing and marketing of products and services for military/aerospace instrumentation test, hard disk drive test and circuit-board test and inspection.

Teradyne evaluates performance based on several factors, of which the primary financial measure is business segment income before income taxes. The accounting policies of the business segments are the same as those described in Note B “Accounting Policies” in Teradyne’s Annual Report on Form 10-K for the year ended December 31, 2010. Segment information is as follows:


	Semiconductor Test		Systems Test Group			Corporate and Eliminations			Consolidated
	(in thousands)
*Three months ended October 2, 2011:*
Net revenues	$	241,394	$	102,995		$	—		$	344,389
Income (loss) from continuing operations before income taxes(1)(2)		35,608		25,238			(4,342	)		56,504
*Three months ended October 3, 2010:*
Net revenues	$	448,273	$	43,118		$	—		$	491,391
Income (loss) from continuing operations before income taxes(1)(2)		156,303		1,149			(5,142	)		152,310
*Nine months ended October 2, 2011:*
Net revenues	$	903,740	$	228,329		$	—		$	1,132,069
Income (loss) from continuing operations before income taxes(1)(2)		203,501		39,551			(15,209	)		227,843
*Nine months ended October 3, 2010:*
Net revenues	$	1,151,010	$	104,990		$	—		$	1,256,000
Income (loss) from continuing operations before income taxes(1)(2)		363,300		(10,325	)		(14,663	)		338,312

(1)	Interest income and interest expense and other are included in Corporate and Eliminations.

(2)	Included in the income (loss) from continuing operations before income taxes for each of the segments are charges for the three months and nine months ended October 2, 2011 and October 3, 2010 that include restructuring and other, net, and provision for excess and obsolete inventory, as follows:

Included in the Semiconductor Test segment are charges for the following:


	For the Three Months Ended				For the Nine Months Ended
	October 2, 2011		October 3, 2010		October 2, 2011		October 3, 2010
	(in thousands)
Cost of revenues—provision for excess and obsolete inventory	$	4,202	$	3,500	$	10,144	$	3,996
Restructuring and other, net		137		91		2,307		1,172

Included in the Systems Test Group segment are charges for the following:


	For the Three Months Ended					For the Nine Months Ended
	October 2, 2011		October 3, 2010			October 2, 2011			October 3, 2010
	(in thousands)
Cost of revenues—provision for excess and obsolete inventory	$	211	$	227		$	612		$	1,185
Restructuring and other, net		—		(1,984	)		(246	)		(1,755	)

Included in the Corporate and Eliminations segment are charges for the following:


	For the Three Months Ended					For the Nine Months Ended
	October 2, 2011		October 3, 2010			October 2, 2011		October 3, 2010
	(in thousands)
Restructuring and other, net	$	1,328	$	(84	)	$	1,096	$	(120	)

Q. Stock Repurchase Program

In November 2010, the Board authorized a stock repurchase program for up to $200 million. For the three months ended October 2, 2011, and cumulatively as of October 2, 2011, Teradyne repurchased 2.0 million shares of common stock for $23.9 million at an average price of $12.06.

R. Subsequent Event

On October 5, 2011, Teradyne completed its acquisition of LitePoint Corporation (“LitePoint”) located in Sunnyvale, California, for approximately $510 million, net of LitePoint’s cash and tax benefits, and up to $70 million payable upon achievement of certain performance targets through 2012. The acquisition was completed by acquiring all of the outstanding common and preferred stock of LitePoint. The fair value of assets and liabilities acquired has not been disclosed because Teradyne has not completed the valuation.

LitePoint designs, develops, and supports advanced wireless test solutions for developers of wireless devices and consumer electronics, contract manufacturers, and wireless integrated circuit designers. The acquisition will allow Teradyne to expand its served market into wireless product testing.

Item 2:

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Statements in this Quarterly Report on Form 10-Q which are not historical facts, so called “forward looking statements,” are made pursuant to the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that all forward looking statements involve risks and uncertainties, including those detailed in Teradyne’s filings with the Securities and Exchange Commission. See also Part II, Item 1A of this Quarterly Report on Form 10-Q and Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2010. Readers are cautioned not to place undue reliance on these forward-looking statements which reflect management’s analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.

Overview

We are a leading global supplier of automatic test equipment. We design, develop, manufacture, and sell automatic test systems and solutions used to test complex electronics in the consumer electronics, automotive, computing, telecommunications, and aerospace and defense industries. Our automatic test equipment products and services include:

•

semiconductor test (“Semiconductor Test”) systems; and

•

military/aerospace (“Mil/Aero”) test instrumentation and systems, hard disk drive test (“HDD”) systems and circuit-board test and inspection (“Commercial Board Test”) systems (collectively these products represent “Systems Test Group”).

We have a broad customer base which includes integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), wafer foundries, fabless companies that design, but contract with others for the manufacture of integrated circuits (“ICs”), manufacturers of circuit boards, HDD manufacturers, aerospace and military contractors as well as the United States Department of Defense.

The sales of our products and services are dependent, to a large degree, on customers who are subject to cyclical trends in the demand for their products. These cyclical periods have had, and will continue to have, a significant effect on our business since our customers often delay or accelerate purchases in reaction to changes in their businesses and to demand fluctuations in the semiconductor industry. Historically, these demand fluctuations have resulted in significant variations in our results of operations. This was particularly relevant beginning in the fourth quarter of fiscal year 2008 where we saw a significant decrease in revenue in our Semiconductor Test business which was impacted by the deteriorating global economy, which negatively impacted the entire semiconductor industry. The sharp swings in the semiconductor industry in recent years have generally affected the semiconductor test equipment and services industry more significantly than the overall capital equipment sector.

Commencing in the fourth quarter of 2009, we experienced improvement in our Semiconductor Test business. We believe our acquisitions of Nextest and Eagle Test and our entry into the high speed memory and HDD markets have enhanced our opportunities for growth. We will continue to invest in our business to expand further our addressable markets while tightly managing our costs. As the last seven quarters have demonstrated, with our current cost structure, we can achieve significantly higher profitability than we achieved at comparable revenue levels in the past.

We regularly face price competition in each of our businesses. More recently, we have been subject to greater price competition in the Semiconductor Test segment. We intend to respond to competitive pricing moves as necessary, which may adversely impact our gross margins. Longer term, we will continue to invest in engineering to lower the cost of test which should help mitigate the impacts from aggressive pricing actions.

On March 21, 2011, we completed the sale of our Diagnostic Solutions business unit, which was included in the Systems Test Group segment, to SPX Corporation for $40.2 million in cash. We sold this business as its growth potential as a stand-alone business was significantly less than if it was part of a larger automotive supplier. The financial information for Diagnostic Solutions has been reclassified to discontinued operations.

On October 5, 2011, we completed our acquisition of LitePoint Corporation (“LitePoint”) for approximately $510 million, net of LitePoint’s cash and tax benefits, and up to $70 million payable upon achievement of certain performance targets through 2012. LitePoint designs, develops, and supports advanced wireless test solutions for the development and manufacturing of wireless devices, including smart phones, tablets, notebooks/laptops, personal computer peripherals, and other Wi-Fi enabled devices.

Critical Accounting Policies and Estimates

We have identified the policies which are critical to understanding our business and our results of operations. There have been no significant changes during the nine months ended October 2, 2011 to the items disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended December 31, 2010.

SELECTED RELATIONSHIPS WITHIN THE CONDENSED CONSOLIDATED

STATEMENTS OF OPERATIONS


	For the Three Months Ended						For the Nine Months Ended
	October 2, 2011			October 3, 2010			October 2, 2011			October 3, 2010
Percentage of total net revenues:
Net revenue:
Products		80	%		88	%		82	%		86	%
Services		20			12			18			14

Total net revenues		100			100			100			100
Cost of revenues:
Cost of products		40			38			40			38
Cost of services		10			6			9			7

Total cost of revenues		50			44			49			45

Gross profit		50			56			51			55
Operating expenses:
Engineering and development		14			10			13			12
Selling and administrative		16			12			15			14
Acquired intangible asset amortization		2			1			2			2
Restructuring and other, net		—			—			—			—

Total operating expenses		32			23			30			27

Income from operations		17			32			21			28
Interest & other		(1	)		(1	)		(1	)		(1	)

Income from continuing operations before income taxes		16			31			20			27
Income tax provision		1			1			1			2

Income from continuing operations		16			30			19			25
Income from discontinued operations before income taxes		—			—			—			—
Income tax benefit		—			—			—			—

Income from discontinued operations		—			—			—			—
Gain on disposal of discontinued operations		—			—			2			—

Net income		16	%		30	%		21	%		25	%

Results of Operations

Third Quarter 2011 Compared to Third Quarter 2010

Book to Bill Ratio

Book to bill ratio is calculated as net bookings divided by net sales. Book to bill ratio by reportable segment was as follows:


	For the Three Months Ended
	October 2, 2011		October 3, 2010
Semiconductor Test		0.8		0.6
Systems Test Group		0.4		1.9
Total Company		0.7		0.7

Revenue

Net revenues for our two reportable segments were as follows:


	For the Three Months Ended				Dollar Change
	October 2, 2011		October 3, 2010		Dollar Change
	(in millions)
Semiconductor Test	$	241.4	$	448.3	$	(206.9	)
Systems Test Group		103.0		43.1		59.9

	$	344.4	$	491.4	$	(147.0	)

The decrease of $206.9 million or 46% in Semiconductor Test revenue was due to a decrease across all System-on-Chip and memory product sales partially offset by an increase in System-on-Chip service revenue. The increase in Systems Test Group revenue of $59.9 million or 139% was primarily due to the increase in sales of Hard Disk Drive test systems.

Our revenues by region as a percentage of total net revenue were as follows:


	For the Three Months Ended
	October 2, 2011			October 3, 2010
United States		16	%		12	%
China		13			12
Japan		12			5
Malaysia		11			21
Taiwan		10			15
Singapore		8			9
Korea		8			8
Thailand		8			0
Europe		7			6
Philippines		6			11
Rest of World		1			1

		100	%		100	%

Gross Profit

Our gross profit was as follows:


	For the Three Months Ended						Dollar/Point Change
	October 2, 2011			October 3, 2010			Dollar/Point Change
	(in millions)
Gross Profit	$	169.8		$	271.8		$	(102.0	)
Percent of Total Revenue		49.3	%		55.3	%		(6.0	)

The decrease in gross profit of 6.0 points was the result of a decrease of 4.5 points related to product mix primarily from higher Hard Disk Drive test system sales, a decrease of 2.9 points due to lower volume. These decreases were partially offset by an increase of 1.4 points primarily due to lower variable compensation.

We assess the carrying value of our inventory on a quarterly basis by estimating future demand and comparing that demand against on-hand and on-order inventory positions. Forecasted revenue information is obtained from the sales and marketing groups and incorporates factors such as backlog and future revenue demand. This quarterly process identifies obsolete and excess inventory. Obsolete inventory, which represents items for which there is no demand, is fully reserved. Excess inventory, which represents inventory items that are not expected to be consumed during the next four quarters, is written-down to estimated net realizable value.

During the three months ended October 2, 2011, we recorded an inventory provision of $4.4 million included in cost of revenues, due to the downward revisions to previously forecasted demand levels. Of the $4.4 million of total excess and obsolete provisions recorded in the three months ended October 2, 2011, $4.2 million was related to Semiconductor Test and $0.2 million was related to Systems Test Group.

During the three months ended October 3, 2010, we recorded an inventory provision of $3.7 million included in cost of revenues, due to the downward revisions to previously forecasted demand levels. Of the $3.7 million of total excess and obsolete provisions recorded in the three months ended October 3, 2010, $3.5 million was related to Semiconductor Test and $0.2 million was related to Systems Test Group.

During the three months ended October 2, 2011 and October 3, 2010, we scrapped $4.2 million and $1.6 million of inventory, respectively. During the three months ended October 2, 2011 and October 3, 2010, we sold $1.5 million and $1.3 million, respectively, of previously written-down or written-off inventory. As of October 2, 2011, we had inventory related reserves for amounts which had been written-down or written-off totaling $125.1 million. We have no pre-determined timeline to scrap the remaining inventory.

Engineering and Development

Engineering and development expenses were as follows:


	For the Three Months Ended						Dollar Change
	October 2, 2011			October 3, 2010			Dollar Change
	(in millions)
Engineering and Development	$	46.8		$	49.0		$	(2.2	)
Percent of Total Revenue		13.6	%		10.0	%

The decrease of $2.2 million in engineering and development expenses is due primarily to lower variable compensation.

Selling and Administrative

Selling and administrative expenses were as follows:


	For the Three Months Ended						Dollar Change
	October 2, 2011			October 3, 2010			Dollar Change
	(in millions)
Selling and Administrative	$	55.3		$	60.6		$	(5.3	)
Percent of Total Revenue		16.1	%		12.3	%

The decrease of $5.3 million in selling and administrative expenses is due primarily to lower variable compensation, partially offset by an increase in marketing and selling expenses for new products and customers.

Restructuring and Other, Net

Restructuring

In response to a downturn in the industry in 2008 and 2009, we initiated restructuring activities across all segments to reduce costs, principally through headcount reductions and facility consolidations. The tables below represent activity related to these actions. The remaining accrual for severance and benefits is reflected in the accrued employees’ compensation and withholdings account on the balance sheet and is expected to be paid by July 2012. The remaining accrual for lease payments on vacated facilities is reflected in the other accrued liabilities account and the long-term other accrued liabilities account and is expected to be paid over the lease terms, the latest of which expires in 2013. We expect to pay approximately $0.9 million against the lease accruals over the next twelve months. Our future lease commitments are net of expected sublease income of $0.6 million as of October 2, 2011.


	Severance and Benefits			Facility Exit Costs			Total
	(in thousands)
*Pre-2010 Activities*
Balance at December 31, 2009	$	2,905		$	10,166		$	13,071
Change in estimate		240			(2,672	)		(2,432	)
Cash payments		(3,124	)		(4,193	)		(7,317	)

Balance at December 31, 2010		21			3,301			3,322
Change in estimate		—			(432	)		(432	)
Cash payments		(21	)		(242	)		(263	)

Balance at April 3, 2011		—			2,627			2,627
Cash payments		—			(301	)		(301	)

Balance at July 3, 2011		—			2,326			2,326
Cash payments		—			(211	)		(211	)

Balance at October 2, 2011	$	—		$	2,115		$	2,115

*2010 Activities*
Q1 2010 Activity:
Provision	$	405		$	—		$	405
Cash payments		(405	)		—			(405	)

Balance at December 31, 2010	$	—		$	—		$	—

Q2 2010 Activity:
Provision	$	890		$	—		$	890
Cash payments		(402	)		—			(402	)

Balance at December 31, 2010		488			—			488
Provision		202			—			202
Cash payments		(690	)		—			(690	)

Balance at April 3, 2011	$	—		$	—		$	—

Q3 2010 Activity:
Provision	$	382		$	—		$	382
Cash payments		(72	)		—			(72	)
Other		(184	)		—			(184	)

Balance at December 31, 2010		126			—			126
Change in estimate		(47	)		—			(47	)
Cash payments		(79	)		—			(79	)

Balance at April 3, 2011	$	—		$	—		$	—

Q4 2010 Activity:
Provision	$	98		$	—		$	98

Balance at December 31, 2010		98			—			98
Provision		117			—			117
Cash payments		(215	)		—			(215	)

Balance at April 3, 2011	$	—		$	—		$	—


	Severance and Benefits			Facility Exit Costs		Total
	(in thousands)
*2011 Activity*
Q1 2011 Activity:
Provision	$	572		$	—	$	572
Cash payments		(241	)		—		(241	)

Balance at April 3, 2011		331			—		331
Cash payments		(154	)		—		(154	)

Balance at July 3, 2011		177			—		177
Change in estimate		(9	)		—		(9	)
Cash payments		(43	)		—		(43	)

Balance at October 2, 2011	$	125		$	—	$	125

Q2 2011 Activity:
Provision	$	344		$	—	$	344

Balance at July 3, 2011		344			—		344
Cash payments		(57	)		—		(57	)

Balance at October 2, 2011	$	287		$	—	$	287

Balance at October 2, 2011	$	412		$	2,115	$	2,527

During the three months ended October 2, 2011, we did not record any restructuring charges.

During the three months ended October 3, 2010, we recorded the following restructuring charges:

Q3 2010 Actions:

•

$0.4 million of severance charges related to headcount reductions of approximately 10 people in Systems Test Group.

Q2 2010 Actions:

•

$0.1 million of additional severance charges related to headcount reductions in Semiconductor Test.

Q2 2009 Actions:

•

$(0.1) million related to a change in the estimated severance benefits related to headcount reduction activities in Semiconductor Test.

Pre-2009 Actions:

•

$(2.4) million credit related to the early exit of previously impaired leased facilities in Westford, Massachusetts.

Other

During the three months ended October 2, 2011, Teradyne recorded a $1.3 million of acquisition costs.

Interest and Other

Interest income increased by $1.6 million, from the third quarter of 2010 to 2011, due primarily to a gain from sales of marketable securities.

Income Taxes

For the three months ended October 2, 2011, we recorded a tax provision of $1.8 million from continuing operations, which consisted of U.S. state and foreign taxes. For the three months ended October 3, 2010, we recorded a tax provision of $6.6 million from continuing operations, which consisted primarily of foreign taxes. Due to the continued uncertainty of realization, we have maintained our valuation allowance at October 2, 2011 for deferred tax assets in the U.S. and Singapore. We will continue to assess the level of the valuation allowance required in future periods. Should more positive than negative evidence regarding the realizability of tax attributes exist in a future period, the valuation allowance may be reduced or eliminated altogether. The factors and evidence being considered include, but are not limited to, the cumulative profit or loss position, the amount and extent of future projected earnings, changes in our business (including mergers and acquisitions) and volatility of the industries we operate in, primarily the semiconductor industry. We may have sufficient positive evidence in the near term that may result in the reduction of the valuation allowance. Reduction of the valuation allowance, in whole or in part, would result in a significant non-cash income tax benefit during the period of reduction.

Nine Months of 2011 Compared to Nine Months of 2010

Revenue

Net revenues for our two reportable segments were as follows:


	For the Nine Months Ended				Dollar Change
	October 2, 2011		October 3, 2010		Dollar Change
	(in millions)
Semiconductor Test	$	903.8	$	1,151.0	$	(247.2	)
Systems Test Group		228.3		105.0		123.3

	$	1,132.1	$	1,256.0	$	(123.9	)

The decrease of $247.2 million or 21% in Semiconductor Test revenue was due to a decrease in System-on-Chip product sales, partially offset by an increase in memory product sales and service revenue. The increase of $123.3 million or 117% in Systems Test Group revenue was primarily due to the increase in sales of Hard Disk Drive test systems.

Our revenues by region as a percentage of total net revenue were as follows:


	For the Nine Months Ended
	October 2, 2011			October 3, 2010
United States		15	%		14	%
Taiwan		12			21
Korea		12			7
Malaysia		11			14
China		11			9
Philippines		10			11
Japan		8			5
Europe		7			5
Thailand		7			3
Singapore		6			10
Rest of World		1			1

		100	%		100	%

Gross Profit

Our gross profit was as follows:


	For the Nine Months Ended						Dollar/Point Change
	October 2, 2011			October 3, 2010			Dollar/Point Change
	(in millions)
Gross Profit	$	577.3		$	692.6		$	(115.3	)
Percent of Total Revenue		51.0	%		55.1	%		(4.1	)

The decrease of 4.1 points was the result of a decrease of 3.1 points related to product mix primarily from higher Hard Disk Drive test system sales, a decrease of 0.6 points due to higher inventory provisions and a decrease of 0.4 points due to lower volume.

During the nine months ended October 2, 2011, we recorded an inventory provision of $10.8 million included in cost of revenues due to the downward revisions to previously forecasted demand levels. Of the $10.8 million of total excess and obsolete provisions recorded in the nine months ended October 2, 2011, $10.2 million was related to Semiconductor Test and $0.6 million was related to Systems Test Group.

During the nine months ended October 3, 2010, we recorded an inventory provision of $5.2 million included in cost of revenues, due to the downward revisions to previously forecasted demand levels. Of the $5.2 million of total excess and obsolete provisions recorded in the nine months ended October 3, 2010, $4.0 million was related to Semiconductor Test and $1.2 million was related to Systems Test Group.

During the nine months ended October 2, 2011 and October 3, 2010, we scrapped $6.8 million and $3.6 million of inventory, respectively. During the nine months ended October 2, 2011 and October 3, 2010, we sold $5.2 million and $6.5 million, respectively, of previously written-down or written-off inventory. As of October 2, 2011, we had inventory related reserves for amounts which had been written-down or written-off totaling $125.1 million. We have no pre-determined timeline to scrap the remaining inventory.

Engineering and Development

Engineering and development expenses were as follows:


	For the Nine Months Ended						Dollar Change
	October 2, 2011			October 3, 2010			Dollar Change
	(in millions)
Engineering and Development	$	142.2		$	146.3		$	(4.1	)
Percent of Total Revenue		12.6	%		11.6	%

The decrease of $4.1 million in engineering and development expenses is due primarily to lower variable compensation.

Selling and Administrative

Selling and administrative expenses were as follows:


	For the Nine Months Ended						Dollar Change
	October 2, 2011			October 3, 2010			Dollar Change
	(in millions)
Selling and Administrative	$	171.0		$	173.0		$	(2.0	)
Percent of Total Revenue		15.1	%		13.8	%

The decrease of $2.0 million in selling and administrative expenses is due primarily to lower variable compensation, partially offset by an increase in marketing and selling expenses for new products and customers.

Restructuring and Other, Net

Restructuring


	Severance and Benefits			Facility Exit Costs			Total
	(in thousands)
*Pre-2010 Activities*
Balance at December 31, 2009	$	2,905		$	10,166		$	13,071
Change in estimate		240			(2,672	)		(2,432	)
Cash payments		(3,124	)		(4,193	)		(7,317	)

Balance at December 31, 2010		21			3,301			3,322
Change in estimate		—			(432	)		(432	)
Cash payments		(21	)		(242	)		(263	)

Balance at April 3, 2011		—			2,627			2,627
Cash payments		—			(301	)		(301	)

Balance at July 3, 2011		—			2,326			2,326
Cash payments		—			(211	)		(211	)

Balance at October 2, 2011	$	—		$	2,115		$	2,115

*2010 Activities*
Q1 2010 Activity:
Provision	$	405		$	—		$	405
Cash payments		(405	)		—			(405	)

Balance at December 31, 2010	$	—		$	—		$	—

Q2 2010 Activity:
Provision	$	890		$	—		$	890
Cash payments		(402	)		—			(402	)

Balance at December 31, 2010		488			—			488
Provision		202			—			202
Cash payments		(690	)		—			(690	)

Balance at April 3, 2011	$	—		$	—		$	—


	Severance and Benefits			Facility Exit Costs		Total
	(in thousands)
Q3 2010 Activity:
Provision	$	382		$	—	$	382
Cash payments		(72	)		—		(72	)
Other		(184	)		—		(184	)

Balance at December 31, 2010		126			—		126
Change in estimate		(47	)		—		(47	)
Cash payments		(79	)		—		(79	)

Balance at April 3, 2011	$	—		$	—	$	—

Q4 2010 Activity:
Provision	$	98		$	—	$	98

Balance at December 31, 2010		98			—		98
Provision		117			—		117
Cash payments		(215	)		—		(215	)

Balance at April 3, 2011	$	—		$	—	$	—

*2011 Activity*
Q1 2011 Activity:
Provision	$	572		$	—	$	572
Cash payments		(241	)		—		(241	)

Balance at April 3, 2011		331			—		331
Cash payments		(154	)		—		(154	)

Balance at July 3, 2011		177			—		177
Change in estimate		(9	)		—		(9	)
Cash payments		(43	)		—		(43	)

Balance at October 2, 2011	$	125		$	—	$	125

Q2 2011 Activity:
Provision	$	344		$	—	$	344

Balance at July 3, 2011		344			—		344
Cash payments		(57	)		—		(57	)

Balance at October 2, 2011	$	287		$	—	$	287

Balance at October 2, 2011	$	412		$	2,115	$	2,527

During the nine months ended October 2, 2011, we recorded the following restructuring charges:

Q2 2011 Action:

•

$0.3 million of severance charges related to headcount reductions of 2 people in Semiconductor Test segment.

Q1 2011 Action:

•

$0.6 million of severance charges related to headcount reductions of 5 people in Semiconductor Test segment.

Pre-2010 Actions:

•

Q2 2010 Actions:

•

$0.2 million related to a change in the estimated severance benefits related to headcount reduction activities across both segments.

Q3 2010 Actions:

•

$0.1 million related to a change in the estimated severance benefits related to headcount reduction activities across both segments.

During the nine months ended October 3, 2010, we recorded restructuring charges related to ongoing efforts to lower expenses and our cost structure and an additional charge due to a change in estimated severance benefits related to a prior period activity. The restructuring charges consisted of the following activities:

Q3 2010 Actions:

•

$0.4 million of severance charges related to headcount reductions of 10 people in Systems Test Group.

Q2 2010 Actions:

•

$0.7 million of severance charges related to headcount reductions of approximately 6 people in Systems Test Group

Q1 2010 Actions:

•

$0.4 million of severance charges related to headcount reductions of 4 people in Semiconductor Test.

Q2 2009 Actions:

•

$0.2 million related to a change in the estimated severance benefits related to headcount reduction activities across both segments.

Pre-2009 Actions:

•

$(2.4) million credit related to the early exit of previously impaired leased facilities in Westford, Massachusetts.

Other

During the nine months ended October 2, 2011, we recorded $1.3 million of acquisition costs, and $0.9 million charge related to a non-U.S. pension settlement.

Interest and Other

Interest expense and other decreased by $2.1 million, from the first nine months of 2010 to 2011, primarily due to a loss on the exercise of the auction rate securities related UBS Put recorded in the second quarter of 2010, partially offset by higher convertible debt discount amortization in 2011.

Income Taxes

For the nine months ended October 2, 2011, we recorded a tax provision of $15.1 million from continuing operations, which consisted of U.S. state and foreign taxes. For the nine months ended October 3, 2010, we recorded a tax provision of $20.9 million from continuing operations, which consisted primarily of foreign taxes. Due to the continued uncertainty of realization, we have maintained our valuation allowance at October 2, 2011 for deferred tax assets in the U.S. and Singapore. We will continue to assess the level of the valuation allowance required in future periods. Should more positive than negative evidence regarding the realizability of tax attributes exist in a future period, the valuation allowance may be reduced or eliminated altogether. The factors and evidence being considered include, but are not limited to, the cumulative profit or loss position, the amount and extent of future projected earnings, changes in our business (including mergers and acquisitions) and volatility of the industries we operate in, primarily the semiconductor industry. We may have sufficient positive evidence in the near term that may result in the reduction of the valuation allowance. Reduction of the valuation allowance, in whole or in part, would result in a significant non-cash income tax benefit during the period of reduction.

Contractual Obligations

The following table reflects our contractual obligations as of October 2, 2011:


	Payments Due by Period
	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years		Other
Long-Term Debt Obligations (1)	$	196,510	$	2,605	$	193,905	$	—	$	—	$	—
Interest on Debt		21,478		8,598		12,880		—		—		—
Operating Lease Obligations		32,429		11,657		13,902		6,316		554		—
Purchase Obligations		132,200		127,300		4,900		—		—		—
Retirement Plan Contributions		78,805		3,291		8,435		8,973		58,106		—
Other Long-Term Liabilities Reflected on the Balance Sheet under GAAP (2)		68,212		—		40,669		—		—		27,543

Total	$	529,634	$	153,451	$	274,691	$	15,289	$	58,660	$	27,543

(1)	Long-Term Debt Obligations include current maturities

(2)

Included in Other Long-Term Liabilities are liabilities for customer advances, extended warranty, uncertain tax positions and other obligations. For certain long-term obligations, we are unable to provide a reasonably reliable estimate of the timing of future payments relating to these obligations and therefore we included these amounts in the column marked “Other”.

Liquidity and Capital Resources

Our cash, cash equivalents and marketable securities balance increased by $176.9 million in the first nine months of 2011, to $1.2 billion. Cash activity for the nine months ended October 2, 2011 and October 3, 2010 was as follows:


	For the Nine Months Ended
	October 2, 2011			October 3, 2010
	(in millions)
Cash provided by operating activities:
Income from continuing operations, adjusted for non-cash items	$	323.4		$	421.3
Change in operating assets and liabilities, net of businesses sold		(104.6	)		(35.2	)
Cash (used for) provided by discontinued operations		(4.2	)		3.7

Total cash provided by operating activities		214.6			389.8

Cash provided by (used for) investing activities from continuing operations		452.9			(412.5	)
Cash provided by investing activities from discontinued operations		39.1			—

Total cash provided by (used for) investing activities		492.0			(412.5	)

Total cash (used for) provided by financing activities		(9.2	)		39.9

Increase in cash and cash equivalents	$	697.4		$	17.2

In the nine months ended October 2, 2011, changes in operating assets and liabilities, net of businesses sold, used cash of $104.6 million. This was due to a $10.6 million decrease in operating assets and a $115.2 million decrease in operating liabilities.

The decrease in operating assets was due to a $25.2 million decrease in accounts receivable resulting from increased collections, partially offset by a $13.6 million increase in prepayments due primarily to supplier prepayments and a $1.0 million increase in inventories. The decrease in operating liabilities was due to a $53.3 million decrease in customer advance payments due to shipments of systems prepaid by customers, a $43.9 million decrease in accrued employee compensation due primarily to variable compensation payments, $6.4 million of retirement plan contributions, a $5.0 million decrease in deferred revenue, a $3.4 million decrease in accounts payable due to decreased sales volume, and a $3.1 million decrease in accrued income taxes.

Investing activities during the nine months ended October 2, 2011 provided cash of $452.9 million, due to $1,112.8 million proceeds from sales and maturities of marketable securities, partially offset by $593.3 million used for purchases of marketable securities and $66.6 million used for purchases of property, plant and equipment.

Financing activities during the nine months ended October 2, 2011 used cash of $9.2 million, due to the repurchase of 2.0 million shares of common stock for $23.9 million at an average price of $12.06 per share, $2.5 million for payments on long-term debt, partially offset by $17.2 million from the issuance of common stock under stock option and stock purchase plans.

In the nine months ended October 3, 2010, changes in operating assets and liabilities, net of businesses sold, used cash of $35.2 million. This was due to a $170.3 million increase in operating assets and a $135.1 million increase in operating liabilities. The increase in operating assets was due to an increase in accounts receivable of $181.0 million due to higher sales volume, partially offset by a $9.7 million decrease in inventories due to higher sales volume, and a decrease in prepayments and other assets of $1.0 million. The increase in operating liabilities was due to a $68.5 million increase in customer advance payments, a $66.6 million increase in accounts payable, a $30.1 million increase in accrued employee compensation due to higher variable compensation, a $14.6 million increase in accrued income taxes, and a $7.5 million increase in deferred revenue, partially offset by $50.8 million of retirement plan contributions and a 1.4 million decrease in other accrued liabilities.

Investing activities during the nine months ended October 3, 2010 used cash of $412.5 million, due to $478.2 million used for purchases of marketable securities and $54.0 million used for purchases of property, plant and equipment, partially offset by proceeds from sales of marketable securities that provided cash of $118.6 million, and proceeds from life insurance that provided cash of $1.1 million.

Financing activities during the nine months ended October 3, 2010 provided cash of $39.9 million, $42.2 million was from the issuance of common stock under stock option and stock purchase plans which was partially offset by $2.3 million of cash used for payments on long-term debt.

On October 5, 2011, Teradyne completed its acquisition of LitePoint for approximately $510 million, net of LitePoint’s cash and tax benefits, and up to $70 million payable upon achievement of certain performance targets through 2012. The $510 million was paid in cash. The $70 million performance payment, if earned, may be paid in cash or in stock.

We believe our cash, cash equivalents and marketable securities balance following the acquisition of LitePoint will be sufficient to meet working capital and expenditure needs for at least the next twelve months. We do not have significant cash outside the U.S. that if repatriated would incur additional taxes. In addition, the amount of cash, cash equivalents and marketable securities in the U.S. and our operations in the U.S. provide sufficient liquidity to fund our business activities in the U.S. Inflation has not had a significant long-term impact on earnings.

Equity Compensation Plans

As discussed in Note M “Stock Based Compensation” in our 2010 Form 10-K, we have a 1996 Employee Stock Purchase Plan and a 2006 Equity and Cash Compensation Incentive Plan (the “2006 Equity Plan”).

The purpose of the 1996 Employee Stock Purchase Plan is to encourage stock ownership by all eligible employees of Teradyne. The purpose of the 2006 Equity Plan is to provide equity ownership and compensation opportunities in Teradyne to our employees, officers, directors, consultants and/or advisors. Both plans were approved by our shareholders.

Recently Issued Accounting Pronouncements

In March 2010, FASB issued an Accounting Standards Update 2010-17, “Milestone Method of Revenue Recognition”, to Accounting Standards Codification 605, “Revenue Recognition.” The guidance in this consensus allows the milestone method as an acceptable revenue recognition methodology when an arrangement includes substantive milestones. The guidance provides a definition of substantive milestone and should be applied regardless of whether the arrangement includes single or multiple deliverables or units of accounting. The scope of this consensus is limited to the transactions involving milestones relating to research and development deliverables. The guidance includes enhanced disclosure requirements about each arrangement, individual milestones and related contingent consideration, information about substantive milestones and factors considered in the determination. The consensus is effective prospectively to milestones achieved in fiscal years, and interim periods within those years, after June 15, 2010. We adopted this final consensus prospectively in January 2011 and the adoption had no material impact on our financial position or results of operations.

In May 2011, the FASB issued ASU No. 2011-04, “Fair Value Measurement.” This ASU clarifies the concepts related to highest and best use and valuation premise, blockage factors and other premiums and discounts, the fair value measurement of financial instruments held in a portfolio and of those instruments classified as a component of shareowners’ equity. The guidance includes enhanced disclosure requirements about recurring Level 3 fair value measurements, the use of nonfinancial assets, and the level in the fair value hierarchy of assets and liabilities not recorded at fair value. The provisions of this ASU are effective prospectively for interim and annual periods beginning on or after December 15, 2011. Early application is prohibited. This ASU requires changes in presentation only and we do not expect it will have a material impact on our consolidated financial statements.

In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income.” This ASU intends to enhance comparability and transparency of other comprehensive income components. The guidance provides an option to present total comprehensive income, the components of net income and the components of other comprehensive income in a single continuous statement or two separate but consecutive statements. This ASU eliminates the option to present other comprehensive income components as part of the statement of changes in shareowners’ equity. The provisions of this ASU will be applied retrospectively for interim and annual periods beginning after December 15, 2011. Early application is permitted. This ASU requires changes in presentation only and we do not expect it will have a material impact on our consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-08, “Intangibles-Goodwill and Other (Topic 350): Testing Goodwill for Impairment.” This new guidance is intended to simplify goodwill impairment testing by allowing companies to first assess qualitative factors to determine if it is more likely than not that goodwill might be impaired and whether it is necessary to perform the current two-step goodwill impairment test. This new guidance is effective for goodwill impairment tests performed in interim and annual periods for fiscal years beginning after December 15, 2011, with early adoption permitted. We do not expect this guidance to have a material impact on our consolidated financial statements.

Item 3:

Quantitative and Qualitative Disclosures about Market Risk

For “Quantitative and Qualitative Disclosures about Market Risk” affecting Teradyne, see Item 7a. “Quantitative and Qualitative Disclosures about Market Risks,” in our Annual Report on Form 10-K filed with the SEC on March 1, 2011. There were no material changes in our exposure to market risk from those set forth in our Annual Report for the fiscal year ended December 31, 2010.

Item 4:

Controls and Procedures

As of the end of the period covered by this report, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) promulgated under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective in ensuring that material information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, including ensuring that such material information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

During the period covered by this report, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.

PART II. OTHER INFORMATION

Item 1:

Legal Proceedings

We are subject to various legal proceedings and claims which have arisen in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on our results of operations, financial condition or cash flows.

Item 1A:

Risk Factors

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part I, “Item 1A: Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2010, which could materially affect our business, financial condition or future results. The risk factors described in our Annual Report on Form 10-K remain applicable to our business with the addition of new risk factors set forth below.

The risks described in our Annual Report on Form 10-K are not the only risks that we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

We may not fully realize the benefits of our acquisitions or strategic alliances.

In October 2011, we acquired LitePoint Corporation (“LitePoint”). We may not be able to realize the benefit of acquiring LitePoint or successfully grow LitePoint’s business. We may continue to acquire additional businesses, form strategic alliances or create joint ventures with third parties that we believe will complement or augment our existing businesses. We may not be able to realize the expected synergies and cost savings from the integration with our existing operations of other businesses or technologies that we may acquire. In addition, the integration process for our acquisitions may be complex, costly and time consuming and include unanticipated issues, expenses and liabilities. We may have difficulty in developing, manufacturing and marketing the products of a newly acquired company in a manner that enhances the performance of our combined businesses or product lines and allows us to realize value from expected synergies. Following an acquisition, we may not achieve the revenue or net income levels that justify the acquisition. Acquisitions may also result in one-time charges (such as acquisition-related expenses, write-offs or restructuring charges) or in the future, impairment of goodwill, that adversely affect our operating results. Additionally, we may fund acquisitions of new businesses, strategic alliances or joint ventures by utilizing our cash, raising debt, issuing shares of our common stock, or by other means.

The recent natural disaster in Japan could disrupt our operations and those of our customers and adversely affect our results of operations.

The recent events in Japan, including earthquakes, tsunamis and the related damage, have created economic uncertainty in that country. The combined effect of these events could impact short-term, end-user demand, disrupt our global supply chain for components manufactured in Japan, increase the cost of components that we acquire due to reduced supply, as well as cause other unforeseen effects to our business. As a result of the events in Japan, we purchased buffer inventory for certain components that are sourced in Japan and we may make additional inventory purchases in the future. Based on a review of our global supply chain and the customers’ test facilities we serve in Japan, we do not expect a significant impact on our long-term ability to manufacture and sell our products, however, this situation remains uncertain and there can be no assurance that an adverse effect on our business, financial condition and operating results will not result from these events.

Our operations and the operations of our customers and suppliers are subject to risks of natural catastrophic events, widespread health epidemics, acts of war, terrorist attacks and the threat of domestic and international terrorist attacks, any one of which could result in cancellation of orders, delays in deliveries or other business activities, or loss of customers and could negatively affect our business and results of operations.

Our business is international in nature, with our sales, service and administrative personnel and our customers and suppliers located in numerous countries throughout the world. Our operations and those of our customers and suppliers are subject to disruption for a variety of reasons, including work stoppages, acts of war,

terrorism, health epidemics, fires, earthquakes, hurricanes, volcanic eruptions, energy shortages, telecommunication failures, tsunamis, flooding or other natural disasters. Such disruption could materially increase our costs and expenses as well as cause delays in, among other things, shipments of products to our customers, our ability to perform services requested by our customers, or the installation and acceptance of our products at customer sites. Any of these conditions could have a material adverse effect on our business, financial conditions and results of operations.

Item 2:

Unregistered Sales of Equity Securities and Use of Proceeds

In November 2007, Teradyne’s Board of Directors (the “Board”) authorized a $400 million stock repurchase program. The cumulative repurchases under this program as of December 31, 2008 totaled 8.5 million shares of common stock for $102.6 million at an average price of $12.14 per share. As of November 4, 2008, the Board suspended the stock repurchase program.

In November 2010, the Board cancelled the November 2007 stock repurchase program and authorized a new stock repurchase program for up to $200 million. The cumulative repurchases as of October 2, 2011 totaled 2.0 million shares of common stock for $23.9 million at an average price of $12.06.

The following table includes information with respect to repurchases we made of our common stock during the quarter ended October 2, 2011 (in thousands except per share price):


Period	(a) Total Number of Shares (or units) Purchased		(b) Average Price Paid per Share (or Unit)		(c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs		(d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that may Yet Be Purchased Under the Plans or Programs
July 4, 2011 – July 31, 2011		4	$	12.92		4	$	199,943
August 1, 2011 – August 28, 2011		1,524	$	12.26		1,528	$	181,261
August 29, 2011 – October 2, 2011		450	$	11.38		1,978	$	176,138

		1,978	$	12.06		1,978	$	176,138

We satisfy the minimum withholding tax obligation due upon the vesting and the conversion of restricted stock units into shares of our common stock, by automatically withholding from the shares being issued a number of shares with an aggregate fair market value on the date of such vesting and conversion that would satisfy the withholding amount due.

Item 6:

Exhibits


Exhibit Number		Description

2.1		Agreement and Plan of Merger by and among Teradyne, Inc., Lager Acquisition Corp., and LitePoint Corporation, dated as of September 14, 2011 filed as Exhibit 2.1 to Teradyne’s Current Report on Form 8-K filed October 6, 2011

31.1		Certification of Principal Executive Officer, pursuant to Rule 13a-14(a) of Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)

31.2		Certification of Principal Financial Officer, pursuant to Rule 13a-14(a) of Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)

32.1		Certification pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)

32.2		Certification pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)

101.INS*		XBRL Instance Document

101.SCH*		XBRL Taxonomy Extension Schema Document

101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		XBRL Taxonomy Extension Label Linkbase Document

101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document

XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

TERADYNE, INC.

Registrant

/S/ GREGORY R. BEECHER

Gregory R. Beecher

Vice President,

Chief Financial Officer and Treasurer

(Duly Authorized Officer
and Principal Financial Officer)

November 14, 2011